Mapping Real-World Rheumatoid Arthritis Patients to Clinical Trial Eligibility Criteria

被引：0
|
作者：
Keystone, Edward [1 ]
Olszynski, Wojciech [2 ]
Bessette, Louis [3 ]
Rahman, Proton [4 ]
Rampakakis, Emmanouil [5 ]
Lehman, Allen [6 ]
Asin-Milan, Odalis [6 ]
Nantel, Francois [6 ]
Rachich, Meagan [6 ]
机构：
[1] Univ Toronto, Mt Sinai Hosp, Toronto, ON, Canada
[2] Univ Saskatchewan, Saskatoon, SK, Canada
[3] Laval Univ, Quebec City, PQ, Canada
[4] Mem Univ, St John, NF, Canada
[5] JSS Med Res Inc, Montreal, PQ, Canada
[6] Janssen Inc, Toronto, ON, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2020年 / 47卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
178
引用
收藏
页码：1107 / 1108
页数：2
相关论文
共 50 条
  • [31] Real-world retention rates of biologics in patients with rheumatoid arthritis
    Kenji Takami
    Shigeyoshi Tsuji
    Scientific Reports, 13
  • [32] CLINICAL BENEFITS REPORTED IN AMPLE TRIAL OBSERVED IN A REAL-WORLD (RW) COHORT OF US RHEUMATOID ARTHRITIS (RA) PATIENTS
    Klink, A.
    Han, X.
    Lobo, F.
    Szymialis, R.
    Lam, J.
    Feinberg, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 622 - 623
  • [33] Improving Diversity in Clinical Trials by Using Real-world Data to Define Eligibility Criteria
    Royce, Trevor J.
    Zhao, Yihua
    Ryals, Cleo A.
    JAMA ONCOLOGY, 2023, 9 (04) : 455 - 456
  • [34] Eligibility of real-world patients with metastatic breast cancer for clinical trials
    Batra, Atul
    Kong, Shiying
    Cheung, Winson Y.
    BREAST, 2020, 54 : 171 - 178
  • [35] Eligibility of real-world patients with metastatic breast cancer in clinical trials
    Batra, A.
    Kong, S.
    Rigo, R.
    Cheung, W.
    ANNALS OF ONCOLOGY, 2020, 31 : S70 - S70
  • [36] "Real-world" eligibility for aducanumab depends on clinical setting and patients' journey
    Padovani, Alessandro
    Caratozzolo, Salvatore
    Rozzini, Luca
    Pilotto, Andrea
    Benussi, Alberto
    Tedeschi, Gioacchino
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2022, 70 (02) : 626 - 628
  • [37] Low real-world eligibility rates for nonalcoholic steatohepatitis patients for phase 3 clinical trial criteria application in a large academic health system
    Ilagan-Ying, Ysabel C.
    Xu, Jin
    Lim, Joseph K.
    Do, Albert
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (03) : 424 - 429
  • [38] Rheumatoid Arthritis Real-World Data on Biosimilars
    Walter, Monika
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2020, 117 (33-34): : A1566 - A1566
  • [39] Characteristics and Outcomes of Rheumatoid Arthritis Patients Treated With Upadacitinib in Real-world Canadian Clinical Practice
    Appleton, Tom
    Patel, Jayesh
    Girard, Tanya
    Bailey, Fiona
    Jones, Hannah
    Durand, Caylib
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (07) : 833 - 833
  • [40] Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results
    Santos-Moreno, Pedro
    Castillo, Paola
    Villareal, Laura
    Pineda, Carlos
    Sandoval, Hugo
    Valencia, Omaira
    OPEN ACCESS RHEUMATOLOGY-RESEARCH AND REVIEWS, 2020, 12 : 249 - 256
12345